Investigator
Partha Basu
INTERNATIONAL AGENCY FOR RES ON CANCER · funded by NCI
- Companies
- 1
- Grants
- 3
- Non-dilutive funding
- $720k
- First award
- Aug 15, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
On this record.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- INTERNATIONAL AGENCY FOR RES ON CANCER73momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R37
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs
$301kAug 15, 2023NCIINTERNATIONAL AGENCY FOR RES ON CANCERNIH RePORTER · 11403713 (opens the source filing in a new tab)
- R37
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs
$91kAug 15, 2023NCIINTERNATIONAL AGENCY FOR RES ON CANCERNIH RePORTER · 11403712 (opens the source filing in a new tab)
- R37
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs
$327kAug 15, 2023NCIINTERNATIONAL AGENCY FOR RES ON CANCERNIH RePORTER · 11182533 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources